Immunotherapy has been used in malignancies including melanoma, renal cell carcinoma, and lung cancer. There is now an emerging role for immunotherapy in gastric and esophageal cancers. The use of immunotherapy in the setting of advanced disease has much research and some completed clinical trials. The use in neoadjuvant therapy is less well-defined, but with ongoing clinical trials, surgeons will begin to see many of these patients in their practice.

*Unless otherwise noted, speakers have nothing to disclose.

Moderators

Stephanie Worrell

Presentations:

1. Use of immunotherapy in advanced esophageal cancer - Wayne Hofstetter

2. Current clinical trials and use of immunotherapy in the neoadjuvant setting - Richard Battafarano

3. Clinical outcomes following esophagectomy after immunotherapy - Daniela Molena

4. Panel Discussion